Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy
Condition: Allergy, Peanut Interventions: Drug: ligelizumab; Drug: Placebo Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials